Table 1.
Demographic characteristics
Parameter | Placebo | Tolterodine | Darifenacin (7.5 mg) | Darifenacin (15 mg) |
---|---|---|---|---|
Number | 16 | 19 | 20 | 17 |
Age | 32.8 ± 1.7 | 34.9 ± 2.4 | 35.8 ± 2.3 | 34.1 ± 2.7 |
Women | 10 | 13 | 13 | 11 |
BMI, kg/m2 | 25.1 ± 1 | 26 ± 1 | 28.1 ± 1 | 26.7 ± 0.9 |
All values represent observed mean [95% confidence interval (CI)].